141 related articles for article (PubMed ID: 29705808)
1. Sumoylation Negatively Regulates CSR1-Dependent Prostate Cancer Cell Death.
Luo HR; Liu Y; Wan XD; Li JL; Wu M; Zhang QM; Wu DL; Zhao X; Wang TR
Cell Physiol Biochem; 2018; 46(5):1861-1867. PubMed ID: 29705808
[TBL] [Abstract][Full Text] [Related]
2. Momordin Ic, a new natural SENP1 inhibitor, inhibits prostate cancer cell proliferation.
Wu J; Lei H; Zhang J; Chen X; Tang C; Wang W; Xu H; Xiao W; Gu W; Wu Y
Oncotarget; 2016 Sep; 7(37):58995-59005. PubMed ID: 27449295
[TBL] [Abstract][Full Text] [Related]
3. CSR1 suppresses tumor growth and metastasis of human hepatocellular carcinoma via inhibition of HPIP.
Jiang L; Hu G; Chen FF; Du XY; Liu B; Liu C
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3813-3820. PubMed ID: 28975986
[TBL] [Abstract][Full Text] [Related]
4. CSR1 suppresses tumor growth and metastasis of prostate cancer.
Yu G; Tseng GC; Yu YP; Gavel T; Nelson J; Wells A; Michalopoulos G; Kokkinakis D; Luo JH
Am J Pathol; 2006 Feb; 168(2):597-607. PubMed ID: 16436673
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic Activity of miR-650 in Prostate Cancer Is Mediated by Suppression of CSR1 Expression.
Zuo ZH; Yu YP; Ding Y; Liu S; Martin A; Tseng G; Luo JH
Am J Pathol; 2015 Jul; 185(7):1991-9. PubMed ID: 25956032
[TBL] [Abstract][Full Text] [Related]
6. SUMO protease SENP1 deSUMOylates and stabilizes c-Myc.
Sun XX; Chen Y; Su Y; Wang X; Chauhan KM; Liang J; Daniel CJ; Sears RC; Dai MS
Proc Natl Acad Sci U S A; 2018 Oct; 115(43):10983-10988. PubMed ID: 30305424
[TBL] [Abstract][Full Text] [Related]
7. Interaction of CSR1 with XIAP reverses inhibition of caspases and accelerates cell death.
Zheng ZL; Tan LZ; Yu YP; Michalopoulos G; Luo JH
Am J Pathol; 2012 Aug; 181(2):463-71. PubMed ID: 22683311
[TBL] [Abstract][Full Text] [Related]
8. Cellular stress response 1 down-regulates the expression of epidermal growth factor receptor and platelet-derived growth factor receptor through inactivation of splicing factor 3A3.
Zuo ZH; Yu YP; Martin A; Luo JH
Mol Carcinog; 2017 Feb; 56(2):315-324. PubMed ID: 27148859
[TBL] [Abstract][Full Text] [Related]
9. SUMO-Specific Cysteine Protease 1 Promotes Epithelial Mesenchymal Transition of Prostate Cancer Cells via Regulating SMAD4 deSUMOylation.
Zhang X; Wang H; Wang H; Xiao F; Seth P; Xu W; Jia Q; Wu C; Yang Y; Wang L
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417919
[TBL] [Abstract][Full Text] [Related]
10. CSR1 induces cell death through inactivation of CPSF3.
Zhu ZH; Yu YP; Shi YK; Nelson JB; Luo JH
Oncogene; 2009 Jan; 28(1):41-51. PubMed ID: 18806823
[TBL] [Abstract][Full Text] [Related]
11. SENP1 regulates PTEN stability to dictate prostate cancer development.
Bawa-Khalfe T; Yang FM; Ritho J; Lin HK; Cheng J; Yeh ET
Oncotarget; 2017 Mar; 8(11):17651-17664. PubMed ID: 27852060
[TBL] [Abstract][Full Text] [Related]
12. SUMO-specific protease 1 promotes prostate cancer progression and metastasis.
Wang Q; Xia N; Li T; Xu Y; Zou Y; Zuo Y; Fan Q; Bawa-Khalfe T; Yeh ET; Cheng J
Oncogene; 2013 May; 32(19):2493-8. PubMed ID: 22733136
[TBL] [Abstract][Full Text] [Related]
13. SENP1 deSUMOylates and regulates Pin1 protein activity and cellular function.
Chen CH; Chang CC; Lee TH; Luo M; Huang P; Liao PH; Wei S; Li FA; Chen RH; Zhou XZ; Shih HM; Lu KP
Cancer Res; 2013 Jul; 73(13):3951-62. PubMed ID: 23633483
[TBL] [Abstract][Full Text] [Related]
14. SUMO-specific protease 1 modulates cadmium-augmented transcriptional activity of androgen receptor (AR) by reversing AR SUMOylation.
Wu R; Cui Y; Yuan X; Yuan H; Wang Y; He J; Zhao J; Peng S
Toxicol Lett; 2014 Sep; 229(2):405-13. PubMed ID: 25014244
[TBL] [Abstract][Full Text] [Related]
15. SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells.
Kaikkonen S; Jääskeläinen T; Karvonen U; Rytinki MM; Makkonen H; Gioeli D; Paschal BM; Palvimo JJ
Mol Endocrinol; 2009 Mar; 23(3):292-307. PubMed ID: 19116244
[TBL] [Abstract][Full Text] [Related]
16. Role of desumoylation in the development of prostate cancer.
Cheng J; Bawa T; Lee P; Gong L; Yeh ET
Neoplasia; 2006 Aug; 8(8):667-76. PubMed ID: 16925949
[TBL] [Abstract][Full Text] [Related]
17. SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis.
Shangguan X; He J; Ma Z; Zhang W; Ji Y; Shen K; Yue Z; Li W; Xin Z; Zheng Q; Cao Y; Pan J; Dong B; Cheng J; Wang Q; Xue W
Nat Commun; 2021 Mar; 12(1):1812. PubMed ID: 33753739
[TBL] [Abstract][Full Text] [Related]
18. The SUMO-specific protease SENP1 deSUMOylates p53 and regulates its activity.
Chauhan KM; Chen Y; Chen Y; Liu AT; Sun XX; Dai MS
J Cell Biochem; 2021 Feb; 122(2):189-197. PubMed ID: 32786121
[TBL] [Abstract][Full Text] [Related]
19. MYB regulates the SUMO protease SENP1 and its novel interaction partner UXT, modulating MYB target genes and the SUMO landscape.
Lemma RB; Ledsaak M; Fuglerud BM; Rodríguez-Castañeda F; Eskeland R; Gabrielsen OS
J Biol Chem; 2023 Sep; 299(9):105062. PubMed ID: 37468105
[TBL] [Abstract][Full Text] [Related]
20. SUMO-triggered ubiquitination of NR4A1 controls macrophage cell death.
Zhang L; Xie F; Zhang J; Dijke PT; Zhou F
Cell Death Differ; 2017 Sep; 24(9):1530-1539. PubMed ID: 28622293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
